Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 19 of 93 Results 181 to 190 of 924
Adrenal function recovery after durable OCS-sparing with benralizumab in the PONENTE study
European Respiratory Journal, vol. 60, no. 6, 2103226Contributions to Journals: ArticlesBiomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
European Respiratory Society (ERS) International Congress., 2814Contributions to Journals: AbstractsBurden of severe asthma by biologic use and eligibility: an analysis of the International Severe Asthma Registry
European Respiratory Society (ERS) International Congress., 2143Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1183/13993003.congress-2022.2143
Carbon footprint of inhalers in respiratory treatment: SABA CARBON International
European Respiratory Society (ERS) International Congress., 2901Contributions to Journals: AbstractsCharacterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR)
European Respiratory Society (ERS) International Congress., 308Contributions to Journals: AbstractsCommencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
European Respiratory Society (ERS) International Congress., pp. 1552Contributions to Journals: AbstractsMortality outcomes associated with oral corticosteroid use in patients with COPD
European Respiratory Society (ERS) International Congress., 1819Contributions to Journals: AbstractsOver-the-counter (OTC) short-acting β2-agonist (SABA) purchase and asthma outcomes in SABINA III
European Respiratory Society (ERS) International Congress., 3434Contributions to Journals: AbstractsPatient-reported barriers to accepting a technological adherence package in the MAGNIFY trial
European Respiratory Society (ERS) International Congress., 3402Contributions to Journals: AbstractsPersistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
World Allergy Congress 2022, pp. 383Contributions to Journals: Abstracts